Anika Therapeutics, Inc. (ANIK)
NASDAQ: ANIK · IEX Real-Time Price · USD
27.56
-0.50 (-1.78%)
At close: Jul 19, 2024, 4:00 PM
27.60
+0.04 (0.15%)
Pre-market: Jul 20, 2024, 9:29 AM EDT

Anika Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year Ending
TTM Dec 31, 2023Dec 31, 2022Dec 31, 2021Dec 31, 2020Dec 31, 2019 2018 - 1996
Net Income
-76.83-82.67-14.864.13-23.9827.19
Upgrade
Depreciation & Amortization
13.2516.4516.3416.0313.477.17
Upgrade
Share-Based Compensation
15.1215.2414.3211.095.396.09
Upgrade
Other Operating Activities
50.1749.19-11.38-22.8518.2-3.45
Upgrade
Operating Cash Flow
1.7-1.794.418.413.0737.01
Upgrade
Operating Cash Flow Growth
-35.94%--47.49%-35.73%-64.69%5.98%
Upgrade
Capital Expenditures
-5.85-5.43-7.49-5.14-1.63-2.83
Upgrade
Acquisitions
000-0.48-94.60
Upgrade
Change in Investments
0002.544.9842.52
Upgrade
Other Investing Activities
-----20.01-
Upgrade
Investing Cash Flow
-5.85-5.43-7.49-3.12-71.2639.69
Upgrade
Share Issuance / Repurchase
-4.16-4.170.681.131.52-7.85
Upgrade
Debt Issued / Paid
00-0.28-0.2-0.560
Upgrade
Other Financing Activities
-2.83-2.15-5.25-7.71-4.74-0.29
Upgrade
Financing Cash Flow
-6.98-6.32-4.85-6.78-3.77-8.14
Upgrade
Exchange Rate Effect
0.020.08-0.130.070.33-0.13
Upgrade
Net Cash Flow
-11.11-13.46-8.06-1.43-61.6568.42
Upgrade
Free Cash Flow
-4.14-7.22-3.083.2511.4434.18
Upgrade
Free Cash Flow Growth
----71.55%-66.54%12.94%
Upgrade
Free Cash Flow Margin
-2.45%-4.33%-1.97%2.20%8.77%29.82%
Upgrade
Free Cash Flow Per Share
-0.28-0.49-0.210.230.802.42
Upgrade
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).